Cytogen's latest marketcap:
As of 08/02/2025, Cytogen's market capitalization has reached $41.69 M. According to our data, Cytogen is the 31296th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 41.69 M |
| Revenue (ttm) | 11.31 M |
| Net Income (ttm) | -11,961,542.83 |
| Shares Out | 23.07 M |
| EPS (ttm) | -0.52 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/12/2025 |
Cytogen's yearly market capitalization.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/02/2025 | ₩57.9 B | $41.69 M | -39.36% | 31296 |
| 12/30/2024 | ₩104.62 B | $70.1 M | -59.34% | 25649 |
| 12/28/2023 | ₩257.28 B | $198.1 M | -11.12% | 18883 |
| 12/29/2022 | ₩289.47 B | $228.68 M | -18.62% | 17233 |
| 12/30/2021 | ₩355.72 B | $298.8 M | 47.87% | 16491 |
| 12/30/2020 | ₩240.57 B | $221.32 M | 240.24% | 16238 |
| 12/30/2019 | ₩70.7 B | $60.81 M | 14.09% | 20818 |
| 12/28/2018 | ₩61.97 B | $55.16 M | 20423 |
Company Profile
About Cytogen, Inc.
Cytogen, Inc. is a biotechnology company specializing in blood cancer cell-based Liquid Biopsy applications, headquartered in Seoul, South Korea. Founded in 2010, the company focuses on innovative diagnostic solutions for cancer detection and analysis.
Key Products & Technologies
- Cell Isolators: Utilize high-density microporous chips to enrich Circulating Tumor Cells (CTCs) from human blood and body fluids.
- IF Stainers: Automated immunofluorescent staining systems for precise cell analysis.
- Cell Image Analyzers: Capture immunofluorescent images of cells stained with anti-EpCAM, -CD45, and CK antibodies.
Brand & Market Presence
The company markets its advanced diagnostic tools under the Smart Biopsy brand, catering to medical and research institutions in South Korea and beyond.
Frequently Asked Questions
-
What is Cytogen's (KOSDAQ-217330) current market cap?As of 08/02/2025, Cytogen (including the parent company, if applicable) has an estimated market capitalization of $41.69 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Cytogen (KOSDAQ-217330) rank globally by market cap?Cytogen global market capitalization ranking is approximately 31296 as of 08/02/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.